Perceptive Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $42.3M | Sell |
|
|||||
|
2024
Q4 | $164M | Sell |
|
|||||
|
2024
Q3 | $250M | Buy |
|
|||||
|
2024
Q2 | $208M | Buy |
|
|||||
|
2024
Q1 | $286M | Buy |
|
|||||
|
2023
Q4 | $97.4M | Buy |
|
|||||
|
2023
Q3 | $54.4M | Sell |
|
|||||
|
2023
Q2 | $98.8M | Sell |
|
|||||
|
2023
Q1 | $93.7M | Buy |
|
|||||
|
2022
Q4 | $63.7M | Sell |
|
|||||
|
2022
Q3 | $98.2M | Sell |
|
|||||
|
2022
Q2 | $131M | Sell |
|
|||||
|
2022
Q1 | $203M | Buy |
|
|||||
|
2021
Q4 | $193M | Sell |
|
|||||
|
2021
Q3 | $283M | Buy |
|
|||||
|
2021
Q2 | $285M | Buy |
|
|||||
|
2021
Q1 | $274M | Sell |
|
|||||
|
2020
Q4 | $425M | Sell |
|
|||||
|
2020
Q3 | $332M | Sell |
|
|||||
|
2020
Q2 | $324M | Buy |
|
|||||
|
2020
Q1 | $349M | Buy |
|
|||||
|
2019
Q4 | $261M | Sell |
|
|||||
|
2019
Q3 | $200M | Sell |
|
|||||
|
2019
Q2 | $292M | Sell |
|
|||||
|
2019
Q1 | $116M | Sell |
|
|||||
|
2018
Q4 | $108M | Buy |
|
|||||
|
2018
Q3 | $82M | Buy |
|
|||||
|
2018
Q2 | $74.9M | Sell |
|
|||||
|
2018
Q1 | $104M | Buy |
|
|||||
|
2017
Q4 | $38.2M | Buy |
|
|||||
|
2017
Q3 | $36.6M | Buy |
|
|||||
|
2017
Q2 | $32.1M | Buy |
|
|||||
|
2017
Q1 | $26.6M | Hold |
|
|||||
|
2016
Q4 | $24.8M | Hold |
|
|||||
|
2016
Q3 | $29.4M | Sell |
|
|||||
|
2016
Q2 | $29.3M | Buy |
|
|||||
|
2016
Q1 | $14.2M | Sell |
|
|||||
|
2015
Q4 | $23.2M | Buy |
|
|||||
|
2015
Q3 | $17M | Buy |
|
|||||
|
2015
Q2 | $25.3M | Buy |
|
|||||
|
2015
Q1 | $32.9M | Sell |
|
|||||
|
2014
Q4 | $25.3M | Buy |
|
|||||
|
2014
Q3 | $20.8M | Sell |
|
|||||
|
2014
Q2 | $19.3M | Buy |
|
|||||
|
2014
Q1 | $28.3M | Buy |
|